Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
First Solar
FSLR
|
+$24.3M |
| 2 |
Lamb Weston
LW
|
+$21.6M |
| 3 |
Ovintiv
OVV
|
+$21.3M |
| 4 |
Hubbell
HUBB
|
+$21.3M |
| 5 |
U-Haul Holding Co Series N
UHAL.B
|
+$19.6M |
Top Sells
| 1 |
Apple
AAPL
|
+$627M |
| 2 |
Microsoft
MSFT
|
+$479M |
| 3 |
Amazon
AMZN
|
+$203M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$169M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$150M |
Sector Composition
| 1 | Technology | 25.32% |
| 2 | Healthcare | 16.62% |
| 3 | Consumer Discretionary | 10.98% |
| 4 | Industrials | 9.74% |
| 5 | Consumer Staples | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDMO
1876
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.07M | ﹤0.01% |
150,100
+3,700
| +3% | +$50.9K |
|
|
RPT
1877
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $2.07M | ﹤0.01% |
205,700
+3,900
| +2% | +$39.2K |
|
1878
Gogo Inc
GOGO
$1.31B
| $2.06M | ﹤0.01% |
139,900
+20,400
| +17% | +$301K |
|
1879
Center Bancorp
CNOB
$1.26B
| $2.06M | ﹤0.01% |
85,200
+900
| +1% | +$21.8K |
|
|
CHCT
1880
Community Healthcare Trust
CHCT
$446M
| $2.06M | ﹤0.01% |
57,600
+1,400
| +2% | +$50.1K |
|
1881
PROG Holdings
PRG
$1.4B
| $2.06M | ﹤0.01% |
121,900
-6,300
| -5% | -$106K |
|
1882
UFP Technologies
UFPT
$1.54B
| $2.04M | ﹤0.01% |
+17,300
| New | +$2.04M |
|
1883
PDF Solutions
PDFS
$766M
| $2.04M | ﹤0.01% |
71,400
+700
| +1% | +$20K |
|
1884
Matthews International
MATW
$764M
| $2.04M | ﹤0.01% |
66,896
| – | – |
|
|
UMH
1885
UMH Properties
UMH
$1.29B
| $2.04M | ﹤0.01% |
126,400
+4,200
| +3% | +$67.6K |
|
1886
Kymera Therapeutics
KYMR
$3.36B
| $2.03M | ﹤0.01% |
81,400
+1,700
| +2% | +$42.4K |
|
1887
CryoPort
CYRX
$433M
| $2.03M | ﹤0.01% |
117,100
| – | – |
|
|
HIBB
1888
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $2.03M | ﹤0.01% |
29,700
+500
| +2% | +$34.1K |
|
1889
TTEC Holdings
TTEC
$173M
| $2.01M | ﹤0.01% |
45,600
+1,100
| +2% | +$48.5K |
|
1890
Regenxbio
RGNX
$466M
| $2.01M | ﹤0.01% |
88,700
+1,800
| +2% | +$40.8K |
|
1891
Columbia Financial
CLBK
$1.6B
| $2.01M | ﹤0.01% |
92,988
| – | – |
|
1892
Innoviva
INVA
$1.22B
| $2.01M | ﹤0.01% |
151,500
+3,600
| +2% | +$47.7K |
|
|
SHYF
1893
DELISTED
The Shyft Group
SHYF
| $2M | ﹤0.01% |
80,400
+2,100
| +3% | +$52.2K |
|
1894
Douglas Dynamics
PLOW
$752M
| $2M | ﹤0.01% |
55,200
+800
| +1% | +$28.9K |
|
1895
Sotera Health
SHC
$4.56B
| $1.99M | ﹤0.01% |
239,100
+4,400
| +2% | +$36.7K |
|
1896
The Beauty Health Co
SKIN
$322M
| $1.99M | ﹤0.01% |
218,600
+4,300
| +2% | +$39.1K |
|
1897
Unitil
UTL
$828M
| $1.99M | ﹤0.01% |
38,700
+900
| +2% | +$46.2K |
|
1898
Geron
GERN
$810M
| $1.99M | ﹤0.01% |
821,000
+22,300
| +3% | +$54K |
|
1899
TORM
TRMD
$2.2B
| $1.98M | ﹤0.01% |
69,563
+1,606
| +2% | +$45.8K |
|
|
PRVB
1900
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $1.98M | ﹤0.01% |
187,100
+60,200
| +47% | +$636K |
|